Dexamethsone is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Northwind Pharmaceuticals, Llc. The primary component is Dexamethasone.
| Product ID | 51655-012_256c47ff-6597-4d66-abe5-6340fd814464 |
| NDC | 51655-012 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dexamethsone |
| Generic Name | Dexamethasone |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-08-11 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA084612 |
| Labeler Name | Northwind Pharmaceuticals, LLC |
| Substance Name | DEXAMETHASONE |
| Active Ingredient Strength | 4 mg/1 |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2014-08-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA084612 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-01-21 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA084612 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-08-11 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| DEXAMETHASONE | 4 mg/1 |
| SPL SET ID: | aa30086a-8551-413e-9cf2-6393093cfcfd |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 51655-012 | Dexamethsone | Dexamethsone |
| 0054-3177 | Dexamethasone | Dexamethasone |
| 0054-4179 | Dexamethasone | Dexamethasone |
| 0054-4180 | Dexamethasone | Dexamethasone |
| 0054-4181 | Dexamethasone | Dexamethasone |
| 0054-4182 | Dexamethasone | Dexamethasone |
| 0054-4183 | Dexamethasone | Dexamethasone |
| 0054-4184 | Dexamethasone | Dexamethasone |
| 0054-4186 | Dexamethasone | Dexamethasone |
| 0054-8174 | Dexamethasone | Dexamethasone |
| 0023-3348 | OZURDEX | dexamethasone |